WASHINGTON - FDA is considering forming a task group with PhRMA and other industry representatives to discuss terms of a guidance document on pharmacoeconomic claims, according to Laurie Burke, an epidemiologist at the agency's Division of Drug Marketing, Advertising & Communications (DDMAC).

The task group would be part of a larger effort to solicit outside involvement in FDA's implementation of provisions in the FDA